ダイト(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4577/E24187 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2022/02/18 | 日証協 | 88,757株 | -1.3% | 37,943株 | +132.64% | 116,931株 | +1.9% | 20,001株 | +316.43% |
| 2022/02/10 | 日証協 | 89,924株 | +2.53% | 16,310株 | -28.44% | 114,749株 | +0.09% | 4,803株 | -47.21% |
| 2022/02/04 | 日証協 | 87,706株 | +11.69% | 22,792株 | +35.59% | 114,646株 | +12.56% | 9,098株 | -77.02% |
| 2022/01/28 | 日証協 | 78,524株 | +3.42% | 16,810株 | -5.46% | 101,852株 | +5.6% | 39,599株 | -23.49% |
| 2022/01/21 | 日証協 | 75,924株 | +24.38% | 17,780株 | +323.33% | 96,451株 | +12.09% | 51,758株 | +202.66% |
| 2022/01/14 | 日証協 | 61,044株 | -8.13% | 4,200株 | +162.5% | 86,049株 | +0.59% | 17,101株 | -34.1% |
| 2022/01/07 | 日証協 | 66,444株 | -11.48% | 1,600株 | -87.82% | 85,548株 | -10.74% | 25,948株 | -1.61% |
| 2021/12/30 | 日証協 | 75,064株 | 0% | 13,132株 | 0% | 95,838株 | 0% | 26,372株 | 0% |
| 2021/12/24 | 日証協 | 75,064株 | -10.37% | 13,132株 | -3.56% | 95,838株 | -9.28% | 26,372株 | +8.22% |
| 2021/12/17 | 日証協 | 83,749株 | -14.06% | 13,617株 | -67.68% | 105,642株 | -10.14% | 24,370株 | -51.15% |
| 2021/12/10 | 日証協 | 97,445株 | -14.52% | 42,126株 | -63% | 117,558株 | -4.88% | 49,892株 | -60.47% |
| 2021/12/03 | 日証協 | 113,995株 | -14.47% | 113,849株 | +27.46% | 123,583株 | -63.56% | 126,206株 | -7.75% |
| 2021/11/26 | 日証協 | 133,283株 | +17.13% | 89,324株 | -12.49% | 339,120株 | +91.46% | 136,807株 | +52.08% |
| 2021/11/19 | 日証協 | 113,786株 | +38.77% | 102,069株 | +86.01% | 177,119株 | +22.47% | 89,960株 | +8.2% |
| 2021/11/05 | 日証協 | 62,187株 | -4.47% | 35,579株 | -8.46% | 76,877株 | -0.96% | 8,359株 | -43.52% |
| 2021/10/29 | 日証協 | 65,097株 | +6.14% | 38,867株 | +89.6% | 77,619株 | -3.94% | 14,800株 | -37.82% |
| 2021/10/22 | 日証協 | 61,334株 | -13.63% | 20,500株 | -24.35% | 80,803株 | -5.39% | 23,800株 | +68.77% |
| 2021/10/15 | 日証協 | 71,017株 | -27.42% | 27,100株 | +15.32% | 85,402株 | -16.52% | 14,102株 | +15.29% |
| 2021/10/08 | 日証協 | 97,844株 | -20.05% | 23,500株 | -60.92% | 102,301株 | -10.18% | 12,232株 | -21.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top